Iterum Therapeutics plc — Director's Dealing 2020

Jun 16, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Iterum Therapeutics plc (ITRM)
CIK: 0001659323
Period of Report: 2020-06-13

Reporting Person: Kelly David George (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-06-13	Ordinary Shares	M	11406	—	Acquired	37108	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-13	Restricted Stock Units	$	M	11406	Disposed		Ordinary Shares (11406)	Direct

Footnotes

F1: Restricted stock units converted into ordinary shares on a one-for-one basis upon vesting of the units.

F2: On June 13, 2019, the reporting person was granted an award of 11,406 restricted stock units, which vested on June 13, 2020.